Integrated and seamless execution of Discovery programs – Concept to Clinic
SynVent is Syngene’s proprietary platform for enabling fully integrated, therapeutic drug discovery and development across small molecules and biologics. With SynVent, you get professional and experienced support for your drug discovery projects from concept to clinic. We not only offer advice on integated discovery programs, we can work as an extension of your internal team, helping you set objectives, execute your scientific plan, and support you in making the right decisions at the right time.
SynVent: Experienced at every step – Concept to Clinic
The journey from conceptualization to clinical development is intricate and often lacks a straightforward path. Our specialized SynVent team has been assembled to offer you comprehensive support at each stage of your discovery journey. Through SynVent, we offer a one-stop solution for the management and coordination of drug discovery projects.
SynVent offers seamless progression — Discovery to Development
SynVent seamlessly integrates synthetic and medicinal chemistry, biology, DMPK, and toxicology, while leveraging our extensive drug discovery knowledge and project management proficiency. This approach lets you concentrate on essential milestones and the core scientific requirements.
SynVent IDD platform
A typical Discovery project with SynVent
Collaboratively, we can craft an optimized and cohesive program that generates timely decision-making data. Our team can help you transform your concept into a tangible reality and enhance your prospects of progressing therapeutic candidates into the development phase. We will serve as your primary contact point, linking you with our in-depth internal expertise across all drug discovery phases to address your distinct challenges.
The SynVent advantage
Given that each customer has unique requirements, internal resources, and capacities, we consistently engage in a comprehensive assessment of project objectives and customer-specific needs. This practice allows us to guarantee alignment and construct a cohesive strategy that empowers our customers like you to capitalize on the advantages offered by Syngene as an all-encompassing, cost-efficient solution. This is regardless of where the project stands in the idea-to-IND spectrum. SynVent’s services deliver scientific excellence through streamlined and adaptable business models while safeguarding the intellectual property rights of our customers.
How SynVent enables effortless progression of your Discovery initiatives – Concept to Clinical Reality
- Industry-leading comprehensive capabilities in integrated drug discovery
- Streamlined internal procedures and cutting-edge technologies honed to prioritize both excellence and efficiency, resulting in decreased cycle durations and, consequently, acceleration of customer discovery endeavors
- Unwavering commitment to addressing challenges, devising inventive solutions, ensuring consistent delivery, and fostering innovation in collaboration with our customers
- Reducing intricacies and administrative burdens for our customers
- Guidance from highly skilled and established senior scientists who serve as project leaders, offering a unified point of contact for our customers.
- Proficient counsel on overarching project strategies. Ensuring the protection of intellectual property and providing support for grant applications
Our multidisciplinary team collaborates closely with customers to cultivate creative concepts and ensure top-notch and time-bound outcomes. We have earned an enviable reputation in this field, evidenced in the high rate of returning customers and a well-documented history of our achievements.
SynVent’s current portfolio across Discovery projects, therapeutic areas and modalities
We collaborate with a diverse range of organizations, each of which faces distinct challenges:
- Virtual biotech companies that bring innovative approaches to a target or pathway and need support to transform their concepts into tangible outcomes
- Small biotech companies equipped with groundbreaking platform technologies but need support for the remaining stages of their drug discovery process
- Mid-sized and large pharmaceutical companies looking to outsource a drug discovery program while minimizing overhead costs to deliver a candidate
- University spin-outs seeking a collaborator to validate and develop their ideas in order to facilitate their next round of funding
- Non-profit organizations in search of a partner with extensive expertise across target classes and therapeutic domains to address unmet diseases
- Venture capital funders who need a dependable, expert team to effectively guide a program toward a go/no-go decision.
